HARRIGAN EDMUND
Insider CIK 1177917 · ACAD Director · PHAS Director · BLCM Director · KRTX Director · INCY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INCY INCYTE CORP | A Award | 2026-09-30 | 2026-10-02 | 206 | $121.35 | $25.0K | 23,225 | SEC↗ |
| INCY INCYTE CORP | A Award | 2026-06-30 | 2026-07-02 | 255 | $113.36 | $28.9K | 23,019 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2026-06-08 | 2026-06-10 | 6,111 | — | $0 | 6,111 | SEC↗ |
| INCY INCYTE CORP | A Award | 2026-06-08 | 2026-06-10 | 1,642 | — | $0 | 22,764 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-05-29 | 2026-06-01 | 16,004 | — | $0 | 16,004 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2026-05-29 | 2026-06-01 | 8,107 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-05-29 | 2026-06-01 | 9,311 | — | $0 | 9,311 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2026-05-29 | 2026-06-01 | 8,107 | — | $0 | 43,148 | SEC↗ |
| INCY INCYTE CORP | A Award | 2026-03-31 | 2026-04-02 | 269 | $94.12 | $25.3K | 21,122 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-12-31 | 2026-01-05 | 245 | $98.77 | $24.2K | 20,853 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-09-30 | 2025-10-02 | 289 | $84.81 | $24.5K | 20,608 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-06-30 | 2025-07-02 | 367 | $68.10 | $25.0K | 20,319 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2025-06-10 | 2025-06-12 | 9,216 | — | $0 | 9,216 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-06-10 | 2025-06-12 | 2,518 | — | $0 | 19,952 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2025-05-29 | 2025-06-02 | 9,387 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2025-05-29 | 2025-06-02 | 8,107 | — | $0 | 8,107 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2025-05-29 | 2025-06-02 | 13,793 | — | $0 | 13,793 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2025-05-29 | 2025-06-02 | 9,387 | — | $0 | 35,041 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-03-31 | 2025-04-02 | 363 | $60.55 | $22.0K | 17,434 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-12-31 | 2025-01-03 | 339 | $69.07 | $23.4K | 17,071 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-09-30 | 2024-10-02 | 378 | $66.10 | $25.0K | 16,732 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-06-28 | 2024-07-02 | 409 | $60.62 | $24.8K | 16,354 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2024-06-12 | 2024-06-14 | 12,517 | — | $0 | 12,517 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-06-12 | 2024-06-14 | 2,830 | — | $0 | 15,945 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2024-05-29 | 2024-05-31 | 6,652 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2024-05-29 | 2024-05-31 | 15,959 | — | $0 | 15,959 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2024-05-29 | 2024-05-31 | 9,387 | — | $0 | 9,387 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2024-05-29 | 2024-05-31 | 6,652 | — | $0 | 25,654 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-03-28 | 2024-04-02 | 413 | $56.97 | $23.5K | 13,115 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-12-29 | 2024-01-03 | 423 | $62.79 | $26.6K | 12,702 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-09-29 | 2023-10-03 | 389 | $57.77 | $22.5K | 12,279 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-06-30 | 2023-07-05 | 390 | $62.25 | $24.3K | 11,890 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2023-06-14 | 2023-06-16 | 11,294 | — | $0 | 11,294 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-06-14 | 2023-06-16 | 2,505 | — | $0 | 11,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2023-06-01 | 2023-06-05 | 6,652 | — | $0 | 6,652 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2023-06-01 | 2023-06-05 | 8,552 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2023-06-01 | 2023-06-05 | 11,045 | — | $0 | 11,045 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2023-06-01 | 2023-06-05 | 8,552 | — | $0 | 19,002 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2023-05-19 | 2023-05-19 | 3,750 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2023-05-19 | 2023-05-19 | 3,750 | — | $0 | 9,750 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-03-31 | 2023-04-04 | 326 | $72.27 | $23.6K | 8,995 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-12-30 | 2023-01-04 | 302 | $80.32 | $24.3K | 8,669 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-10-19 | 2022-10-20 | 165 | $69.59 | $11.5K | 8,367 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-09-30 | 2022-10-04 | 250 | $66.64 | $16.7K | 8,202 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-06-30 | 2022-07-01 | 236 | $75.97 | $17.9K | 7,952 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2022-06-15 | 2022-06-17 | 9,124 | — | $0 | 9,124 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-06-15 | 2022-06-17 | 2,144 | — | $0 | 7,716 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2022-06-07 | 2023-06-05 | 6,391 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2022-06-07 | 2023-06-05 | 6,391 | — | $0 | 10,450 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2022-06-07 | 2022-06-09 | 8,552 | — | $0 | 8,552 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2022-06-07 | 2022-06-09 | 14,368 | — | $0 | 14,368 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 3,750 | — | $0 | 3,750 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-03-31 | 2022-04-04 | 240 | $79.42 | $19.1K | 5,572 | SEC↗ |
| INCY INCYTE CORP | A Award | 2021-12-31 | 2022-01-04 | 253 | $73.40 | $18.6K | 5,332 | SEC↗ |
| INCY INCYTE CORP | A Award | 2021-09-30 | 2021-10-04 | 237 | $68.78 | $16.3K | 5,079 | SEC↗ |
| INCY INCYTE CORP | A Award | 2021-06-30 | 2021-07-02 | 208 | $84.13 | $17.5K | 4,842 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2021-06-22 | 2023-06-05 | 3,059 | — | $0 | 0 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2021-06-22 | 2023-06-05 | 3,059 | — | $0 | 4,059 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-06-22 | 2021-06-24 | 6,391 | — | $0 | 6,391 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2021-06-22 | 2021-06-24 | 11,637 | — | $0 | 11,637 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2021-06-03 | 2021-06-04 | 14,000 | — | $0 | 14,000 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2021-05-26 | 2021-05-28 | 8,010 | — | $0 | 8,010 | SEC↗ |
| INCY INCYTE CORP | A Award | 2021-05-26 | 2021-05-28 | 1,923 | — | $0 | 4,634 | SEC↗ |
| INCY INCYTE CORP | A Award | 2021-03-31 | 2021-04-01 | 219 | $81.27 | $17.8K | 2,711 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-12-31 | 2021-01-05 | 207 | $86.98 | $18.0K | 2,492 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2020-12-03 | 2020-12-04 | 6,000 | $4.12 | $24.7K | 6,000 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-09-30 | 2020-10-01 | 187 | $89.74 | $16.8K | 2,285 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | S Sale | 2020-08-12 | 2020-08-14 | 10,000 | $83.32 | $833.2K | 55,163 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | S Sale | 2020-07-13 | 2020-07-13 | 10,000 | $93.40 | $934.0K | 65,163 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-06-30 | 2020-07-01 | 152 | $103.97 | $15.8K | 2,098 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2020-06-23 | 2020-06-25 | 5,579 | — | $0 | 5,579 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2020-06-23 | 2020-06-25 | 3,059 | — | $0 | 3,059 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | S Sale | 2020-06-12 | 2020-06-15 | 30,000 | $91.79 | $2.75M | 75,163 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2020-06-03 | 2020-06-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2020-05-26 | 2020-05-28 | 10,514 | — | $0 | 10,514 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-05-26 | 2020-05-28 | 1,282 | — | $0 | 1,946 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-03-31 | 2020-04-02 | 202 | $73.23 | $14.8K | 664 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award | 2020-03-09 | 2020-03-11 | 105,163 | — | $0 | 105,163 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2019-12-17 | 2019-12-19 | 4,360 | — | $0 | 4,360 | SEC↗ |
| INCY INCYTE CORP | A Award | 2019-12-17 | 2019-12-19 | 462 | — | $0 | 462 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2019-06-27 | 2019-07-01 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2019-06-26 | 2019-06-28 | 22,500 | — | $0 | 22,500 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2019-06-13 | 2019-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-05-09 | 2019-05-13 | 4,583 | — | $0 | 4,583 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2018-12-13 | 2018-12-17 | 68,966 | — | $0 | 68,966 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-06-14 | 2018-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2018-06-06 | 2018-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2018-06-06 | 2018-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-02-20 | 2018-02-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2018-02-20 | 2018-02-22 | 3,166 | — | $0 | 23,166 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2017-07-17 | 2017-07-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2017-06-13 | 2017-06-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | P Buy | 2016-08-16 | 2016-08-18 | 1,000 | $32.97 | $33.0K | 1,000 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2016-06-10 | 2016-06-10 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2015-11-25 | 2015-11-30 | 15,000 | — | $0 | 15,000 | SEC↗ |